p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs

Abstract

Large parts of mammalian genomes are transcriptionally inactive and enriched with various classes of interspersed and tandem repeats. Here we show that the tumor suppressor protein p53 cooperates with DNA methylation to maintain silencing of a large portion of the mouse genome. Massive transcription of major classes of short, interspersed nuclear elements (SINEs) B1 and B2, both strands of near-centromeric satellite DNAs consisting of tandem repeats, and multiple species of noncoding RNAs was observed in p53-deficient but not in p53 wild-type mouse fibroblasts treated with the DNA demethylating agent 5-aza-2'-deoxycytidine. The abundance of these transcripts exceeded the level of β-actin mRNA by more than 150-fold. Accumulation of these transcripts, which are capable of forming double-stranded RNA (dsRNA), was accompanied by a strong, endogenous, apoptosis-inducing type I IFN response. This phenomenon, which we named "TRAIN" (for "transcription of repeats activates interferon"), was observed in spontaneous tumors in two models of cancer-prone mice, presumably reflecting naturally occurring DNA hypomethylation and p53 inactivation in cancer. These observations suggest that p53 and IFN cooperate to prevent accumulation of cells with activated repeats and provide a plausible explanation for the deregulation of IFN function frequently seen in tumors. Overall, this work reveals roles for p53 and IFN that are key for genetic stability and therefore relevant to both tumorigenesis and the evolution of species.interferon alpha-beta receptor | RNA sequencing | epigenetic repression | microarray hybridization

Function of HNRNPC in breast cancer cells by controlling the dsRNA‐induced interferon response

“…Endogenous dsRNA species are some of the primary activators of the interferon response (Leonova et al , 2013; Mannion et al , 2014; White et al , 2014; Chiappinelli et al , 2015; Liddicoat, 2015; Roulois et al , 2015; Goel et al , 2017). Recent studies showed transcriptional activations of the ERVs triggered by several anti‐tumor drugs, which in turn resulted in ERV‐originated dsRNA accumulation, potent interferon responses, and significant tumor inhibition (Chiappinelli et al , 2015; Roulois et al , 2015; Goel et al , 2017).…”

When Competing Viruses Unify: Evolution, Conservation, and Plasticity of Genetic Identities

“…But such LTRs are highly involved in the emergence of new regulatory networks, such as the origin of the placenta (Bièche et al 2003;Chuong et al 2013;Emera and Wagner 2012;Harris 1998;Nakagawa et al 2013) (re-regulating 1500 genes) Lynch et al 2011Lynch et al , 2012 or in the African primates where alteration of 320,000 LTR p53 binding sites occurred onto the p53 cell cycle control network (Wang et al 2007). These primate p53 network changes also relate to (co-operate with) changes in brain specific microRNAs (Le et al 2009), alterations to DNA methylation involved in controlling SINE-derived RNA transcription (Leonova et al 2013), as well as Alu-derived transcription (Zemojtel et al 2009 In proposing the qs-c concept, it was argued that agent diversity (not errors) was essential for the capacity of a collective of RNA agents to function co-operatively (Villarreal and Witzany 2013b). Thus, an identity group of sub-functional RNA agents would be the predecessors of RNA-based life (not a functioning individual).…”

Nuclear PTEN tumor-suppressor functions through maintaining heterochromatin structure

“…Therefore, we included a DNA-demethylating agent, 5-aza-2 0 -deoxycytidine (5-AZA), which was recently shown to be an effective chemotherapeutic agent in satellite DNA overexpressing cells. 28 Interestingly, we discovered that only WT PTEN cells had reduced sensitivity to 5-AZA (Fig. 4F).…”